Patellofemoral arthritis affects the joint between the kneecap and thigh bone. Learn how stem cell therapy is being studied as a non-surgical option for this condition.
Patellofemoral arthritis is a form of knee arthritis that affects the joint between the kneecap (patella) and the thigh bone (femur). It often causes pain that differs from typical inner-knee arthritis and can interfere with everyday activities.
The patellofemoral joint sits at the front of the knee, where the kneecap glides over the femur. Cartilage on the back of the kneecap and on the femoral groove allows smooth movement. When this cartilage wears down, the result is patellofemoral knee arthritis. This compartment is heavily loaded during stair climbing, squatting, and prolonged sitting. Its anatomy explains why pain in this condition has a distinct pattern compared with other forms of knee arthritis.
Pain is usually located at the front of the knee, behind or around the kneecap. Symptoms often worsen with stairs, squatting, kneeling, or sitting with the knee bent for long periods. Patients may describe a grinding or clicking sensation behind the kneecap. Stiffness after periods of inactivity, sometimes called the "theater sign", is common. Daily impact ranges from mild discomfort to clear limitation of work and recreational activity.
Multiple factors can contribute to wear in this compartment. Patellar maltracking, where the kneecap does not glide centrally, increases focal stress. A previous kneecap dislocation or direct injury can damage cartilage. Muscle imbalances around the hip and thigh shift force into the patellofemoral joint. Repetitive high-impact loading and age-related cartilage changes also play a role.
Initial management typically focuses on non-surgical approaches. Targeted physical therapy addresses hip strength, quadriceps balance, and movement patterns. Activity modification reduces repeated deep-knee loading that drives symptoms. Bracing or taping can support the kneecap and ease pain during activity. Weight management and anti-inflammatory medications may also be part of the plan.
Mesenchymal stem cell (MSC) therapy is studied as a supportive option for knee osteoarthritis, including patellofemoral involvement. The aim is to lower local inflammation and support the joint environment. Paracrine signaling through growth factors and exosomes is considered central to these effects. Patients with earlier or moderate cartilage changes may be better positioned to respond. Specific clinical evidence on patellofemoral arthritis is more limited than for whole-joint osteoarthritis.
MSC therapy is not a guaranteed cure for patellofemoral knee arthritis. Reported benefits often include reduced pain and improved function over weeks to months. Outcomes depend on severity, alignment, muscle balance, and adherence to rehabilitation. Some patients experience meaningful improvement; others see modest or no change. Honest expectation-setting helps patients make informed decisions about whether to proceed.
Stem cell therapy is best viewed as one component of a comprehensive plan, not a standalone solution. Continued strengthening of the quadriceps, hip, and core supports the kneecap during activity. Movement retraining can correct patterns that contribute to maltracking. Gradual return to high-impact loading helps protect the joint while it adapts. A coordinated approach generally produces more reliable and durable results.
Patellofemoral arthritis can be a frustrating, activity-limiting condition. Stem cell therapy is one option being explored as part of a comprehensive, non-surgical strategy that includes movement and rehabilitation.